Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized neoadjuvant sorafenib plus laser ablation versus laser ablation alone for hepatocellular carcinoma >4 cm
2011-005403-33Phase 2Active
- Sponsor
- Cardarelli Hospital
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in hepatocellular carcinoma (HCC), liver cancer, sponsored by Cardarelli Hospital. Started Dec 2011; status: active.
02
Drugs
sorafenib
03
Conditions
hepatocellular carcinoma (HCC)liver cancer
Beyond the preview
Go deeper on 2011-005403-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005403-33.